{"id":"colchicine-pill","safety":{"commonSideEffects":[{"rate":"10-30","effect":"Diarrhea"},{"rate":"5-15","effect":"Nausea"},{"rate":"5-15","effect":"Abdominal pain"},{"rate":"1-5","effect":"Myopathy"},{"rate":"1-5","effect":"Peripheral neuropathy"}]},"_chembl":{"chemblId":"CHEMBL107","moleculeType":"Small molecule","molecularWeight":"399.44"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Colchicine binds to beta-tubulin and prevents microtubule assembly, which disrupts cell division and inflammatory cell movement. This mechanism reduces the recruitment of neutrophils and other immune cells to sites of inflammation, and decreases the production of pro-inflammatory cytokines like IL-1β and TNF-α. The drug has been used for centuries in gout and is now approved for acute gout flares and familial Mediterranean fever.","oneSentence":"Colchicine inhibits microtubule polymerization by binding to tubulin, thereby suppressing inflammatory cell migration and reducing production of inflammatory mediators.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:30:24.718Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute gout flares"},{"name":"Familial Mediterranean fever (FMF)"},{"name":"Gout prophylaxis"}]},"trialDetails":[{"nctId":"NCT05850091","phase":"PHASE4","title":"Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Intervention With Statin and Colchicine","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2023-12-07","conditions":"Coronary Artery Disease","enrollment":200},{"nctId":"NCT07232069","phase":"PHASE3","title":"PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis","status":"NOT_YET_RECRUITING","sponsor":"Duke University","startDate":"2026-07-01","conditions":"Coronary Artery Disease Risk Factors Multiple, Coronary Artery Disease Progression, Prevention & Control","enrollment":1500},{"nctId":"NCT05855746","phase":"PHASE3","title":"Colchicine Versus Placebo in Acute Myocarditis Patients","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2024-07-16","conditions":"Acute Myocarditis","enrollment":300},{"nctId":"NCT06855433","phase":"PHASE2","title":"Colchicine to Reduce Your SympToms And Lower Levels of Inflammation, Zeroing in on Effective CPPD Disease Treatment","status":"NOT_YET_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2026-04-10","conditions":"CPPD - Calcium Pyrophosphate Deposition Disease","enrollment":150},{"nctId":"NCT06936709","phase":"PHASE4","title":"Perioperative Colchicine for TKA","status":"NOT_YET_RECRUITING","sponsor":"Geisinger Clinic","startDate":"2025-12-01","conditions":"Osteoarthritis of Knee, Recovery Following Primary Total Knee Arthroplasty, Perioperative Pain Control","enrollment":75},{"nctId":"NCT06998862","phase":"PHASE3","title":"Colchicine in Chronic Kidney Disease Patients","status":"RECRUITING","sponsor":"Hospital General Universitario Gregorio Marañon","startDate":"2025-02-12","conditions":"Chronic Kidney Disease, Cardiovascular Events","enrollment":744},{"nctId":"NCT06472908","phase":"PHASE3","title":"Efficacy and Safety of Colchicine After PCI","status":"RECRUITING","sponsor":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","startDate":"2024-07-09","conditions":"Coronary Heart Disease, Percutaneous Coronary Intervention, Colchicine","enrollment":8862},{"nctId":"NCT05159219","phase":"PHASE2","title":"Colchicine for the Prevention of Vascular Events After an Acute Intracerebral Hemorrhage","status":"COMPLETED","sponsor":"Population Health Research Institute","startDate":"2022-08-04","conditions":"Intracranial Hemorrhages","enrollment":100},{"nctId":"NCT06215989","phase":"NA","title":"Treatment of ACuTe Coronary Syndromes With Low-dose colchICine","status":"RECRUITING","sponsor":"Beijing Anzhen Hospital","startDate":"2024-09-02","conditions":"Acute Coronary Syndrome, Unstable Angina, ST Elevation Myocardial Infarction","enrollment":6574},{"nctId":"NCT03874338","phase":"","title":"CLEAR SYNERGY Neutrophil Substudy","status":"COMPLETED","sponsor":"NYU Langone Health","startDate":"2019-03-04","conditions":"Neutrophils.Hypersegmented &#X7C; Bld-Ser-Plas, STEMI - ST Elevation Myocardial Infarction","enrollment":322},{"nctId":"NCT04181996","phase":"PHASE3","title":"Canadian Study of Arterial Inflammation in Patients With Diabetes and Vascular Events: EvaluatioN of Colchicine","status":"RECRUITING","sponsor":"Ottawa Heart Institute Research Corporation","startDate":"2020-08-01","conditions":"Cardiovascular Diseases, Atherosclerosis, Inflammation","enrollment":115},{"nctId":"NCT06078904","phase":"PHASE4","title":"Different Doses of Colchicine on hsCRP","status":"COMPLETED","sponsor":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","startDate":"2023-10-10","conditions":"Coronary Artery Disease, Percutaneous Coronary Intervention","enrollment":200},{"nctId":"NCT04224545","phase":"PHASE4","title":"COlchicine in Cardiac Surgery","status":"COMPLETED","sponsor":"Bakulev Scientific Center of Cardiovascular Surgery","startDate":"2019-12-23","conditions":"Colchicine Adverse Reaction, Atrial Fibrillation New Onset","enrollment":267},{"nctId":"NCT04848857","phase":"PHASE4","title":"Colchicine for the Stability of Coronary Plaque in Acute Coronary Syndrome (COLOCT)","status":"COMPLETED","sponsor":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","startDate":"2021-05-03","conditions":"Acute Coronary Syndrome","enrollment":128},{"nctId":"NCT05335148","phase":"PHASE1","title":"Study to Evaluate the Safety of Colchicine","status":"UNKNOWN","sponsor":"Rutgers, The State University of New Jersey","startDate":"2022-05-10","conditions":"Radiation Therapy","enrollment":30},{"nctId":"NCT03693781","phase":"PHASE2","title":"Colchicine for Amyotrophic Lateral Sclerosis","status":"COMPLETED","sponsor":"Azienda Ospedaliero-Universitaria di Modena","startDate":"2019-04-10","conditions":"Amyotrophic Lateral Sclerosis","enrollment":54},{"nctId":"NCT05745818","phase":"","title":"Colchicine for Reduction of Periprocedural Myocardial Injury in Percutaneous Coronary Intervention","status":"UNKNOWN","sponsor":"Sohag University","startDate":"2023-03-01","conditions":"Periprocedural Myocardial Infarction, Periprocedural Myocardial Injury","enrollment":300},{"nctId":"NCT04367168","phase":"PHASE2","title":"Colchicine in Patients With Mild and Severe Coronavirus Disease","status":"TERMINATED","sponsor":"Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran","startDate":"2020-05-27","conditions":"COVID","enrollment":116},{"nctId":"NCT05459974","phase":"PHASE3","title":"Use of Colchicine to Decrease Atrial Fibrillation Recurrence After Ablation","status":"UNKNOWN","sponsor":"Stony Brook University","startDate":"2022-06-20","conditions":"Atrial Fibrillation","enrollment":224},{"nctId":"NCT04539873","phase":"PHASE3","title":"Impact of Colchicine in Hospitalized Colombian Patients With COVID-19","status":"TERMINATED","sponsor":"Fundación Universitaria de Ciencias de la Salud","startDate":"2021-04-30","conditions":"Corona Virus Infection","enrollment":128},{"nctId":"NCT04139655","phase":"NA","title":"Colchicine Prevents Myocardial Injury After Non-Cardiac Surgery Pilot Study","status":"WITHDRAWN","sponsor":"University of British Columbia","startDate":"2020-09-01","conditions":"Myocardial Infarction, Myocardial Injury, Major Adverse Cardiac Events","enrollment":""},{"nctId":"NCT04359095","phase":"PHASE2, PHASE3","title":"Effectiveness and Safety of Medical Treatment for SARS-CoV-2 (COVID-19) in Colombia","status":"COMPLETED","sponsor":"Universidad Nacional de Colombia","startDate":"2020-08-18","conditions":"COVID-19","enrollment":650},{"nctId":"NCT02551094","phase":"PHASE3","title":"Colchicine Cardiovascular Outcomes Trial (COLCOT)","status":"COMPLETED","sponsor":"Montreal Heart Institute","startDate":"2015-12-04","conditions":"Coronary Artery Disease, Myocardial Infarction","enrollment":4745},{"nctId":"NCT03704181","phase":"PHASE2","title":"Colchicine for Patients With Chagas´ Disease( B1 Stage)","status":"UNKNOWN","sponsor":"University of Sao Paulo General Hospital","startDate":"2018-10-01","conditions":"Chagas Disease, Colchicine Resistance","enrollment":60},{"nctId":"NCT02177266","phase":"PHASE3","title":"Colchicine to Prevent Post-Pericardiotomy Syndrome and Atrial Fibrillation","status":"TERMINATED","sponsor":"Mayo Clinic","startDate":"2015-05","conditions":"Atrial Fibrillation, Post-pericardiotomy Syndrome, Constriction","enrollment":2},{"nctId":"NCT01160276","phase":"PHASE1","title":"Drug Interaction Between Colchicine and Calcineurin Inhibitors in Renal Graft Recipients","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2010-05","conditions":"Renal Replacement Therapies","enrollment":17}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":12,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Colchicine","Colchicine 0.5 MG","group C"],"phase":"marketed","status":"active","brandName":"Colchicine Pill","genericName":"Colchicine Pill","companyName":"Brigham and Women's Hospital","companyId":"brigham-and-women-s-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Colchicine inhibits microtubule polymerization by binding to tubulin, thereby suppressing inflammatory cell migration and reducing production of inflammatory mediators. Used for Acute gout flares, Familial Mediterranean fever (FMF), Gout prophylaxis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":3,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}